Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    2 0 0 0

Néphrologie & Thérapeutique
Volume 13, n° S1
pages 155-156 (avril 2017)
Doi : 10.1016/j.nephro.2017.02.004
Syndromes hypertrophiques secondaires aux mutations de PIK3CA
PIK3CA- related overgrowth syndrome (PROS)

Quitterie Venot a, Guillaume Canaud a, , b, c
a Inserm U1151, hôpital Necker-Enfants malades, 149, rue de Sèvres, 75015 Paris, France 
b Université Paris Descartes, Sorbonne Paris Cité, 149, rue de Sèvres, 75015 Paris, France 
c Service de néphrologie transplantation adultes, hôpital Necker-Enfants malades, 149, rue de Sèvres, 75015 Paris, France 

Auteur correspondant.

Cette revue traite des syndromes hypertrophiques liées à une mutation somatique du gène PIK3CA . Cette entité nouvellement décrite englobe un grand nombre de syndromes dysmorphiques ayant comme point commun une mutation activatrice du gène PIK3CA . Les aspectes cliniques, diagnostics moléculaires et prise en charge thérapeutiques sont discutés.

The full text of this article is available in PDF format.

This review presents an overview of a recently characterized spectrum of overgrowth syndrome: phosphoinositide-3 kinase (PI3K)-related overgrowth spectrum (PROS). This spectrum encompasses overgrowth syndromes associated with somatic mosaic activating PIK3CA mutations such as megalencephaly-capillary malformation (MCAP) syndrome, dysplatic megalencephaly (DMEG), congenital lipomatous asymmetric overgrowth of the trunk, lymphatic, capillary, venous, and combined-type vascular malformations, epidermal nevi, skeletal and spinal anomalies (CLOVES) syndrome, hemihyperplasia-multiple lipomatosis (HHML), fibroadipose overgrowth and Klippel-Trenaunay syndrome. Mosaic gain of function mutation in PIK3CA gene leads to abnormal AKT-mTOR pathway activation and is responsible of the clinical manifestations. Here, we summarize the current knowledge on this disorder.

The full text of this article is available in PDF format.

Mots clés : PIK3CA, Hypertrophie, Diagnostic, Traitement

Keywords : PIK3CA, Hypertophy, Diagnosis and therapeutics

© 2017  Société francophone de néphrologie, dialyse et transplantation@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline